ORTEXORTEX News
Tracking XLU? Get live short interest, options flow, and signals on ORTEX.Sign up free →
XL
Trader NoteXLU

XLU Short Interest Jumps 31% in a Week, Hitting a New 12-Month High

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 28 Oct 2026, 19:14

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

XLU, the utilities sector ETF, now carries more short interest than any of its closest sector-ETF peers this week, with 16.8% of free float sold short after a 31% rise over the past five trading days.

That week-on-week jump is the standout number. Short interest had been tracking between 12% and 13% of free float for most of October, a level already elevated for a broad passive vehicle. Then between October 21 and October 23 it jumped sharply, from roughly 32 million shares short to 34.8 million in a single session, and climbed further to 41.8 million by October 27. The result is a new 12-month peak, and the weekly move sits 1.9 standard deviations above XLU's typical weekly swing. For an ETF that tends to attract incremental hedging rather than high-conviction short bets, that kind of acceleration stands out.

The borrow market has tightened in step with the short build, though conditions remain manageable. Availability has fallen sharply, from over 800% of short interest a week ago to 198% now, meaning roughly two shares remain available for every one already borrowed. That is still a loose enough market that new positions can be added without material cost pressure. Cost to borrow has risen 30% over the week to 0.54%, and is up 149% over the past month, yet in absolute terms it remains low. The borrow side reinforces the message that shorts have been added quickly, but the squeeze risk that was briefly visible in late September, when availability touched a 52-week low near 5%, is not present today.

Options positioning has turned more defensive than it was a week ago, though it has not returned to the extremes of late September. The put/call ratio is at 1.61, about 1.26 standard deviations above the 20-day mean of 1.40. That is a meaningful shift from the neutral reading flagged in the previous note published October 21, when the PCR was essentially in line with its average. The past week's rise in the PCR has happened alongside the short interest acceleration, suggesting that both the equity and options markets are expressing more caution on utilities simultaneously.

The ORTEX short score has also moved in the same direction, rising from 40.4 on October 19 to 55.2 by October 27, its highest reading in the period captured. The score reflects the combination of rising short interest, tightening availability and elevated options defensiveness, and the ten-point move over eight sessions is not a trivial shift for an ETF that tends to move slowly on this measure.

On the institutional side, the most recent 13F data (June 30) shows broad-based net selling among the top holders. Morgan Stanley trimmed by 1.4 million shares, UBS cut by 7.1 million, and Merrill Lynch reduced by 2.2 million. Bank of America, Goldman Sachs and BNP Paribas were the notable buyers in the same period. Those flows are now four months old and predate the short interest acceleration, so they provide context rather than a current read.

The next level to watch is whether short interest consolidates around 17% of free float or continues to push toward last year's tightest availability episode. The September squeeze, when availability briefly dropped to 5.4%, offers the reference point for how quickly borrow conditions can move when a short build meets limited lending supply.

Stocks in this article

See the live data behind this article on ORTEX.

Open XLU on ORTEX →

How this article was generated

Generated
28 Oct 2026, 19:14
Data as of
28 Oct 2026, 19:14
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.